The U.S. FDA approved two Teva Pharmaceutical Industries Ltd. asthma inhalers.
The inhalers, AirDuo RespiClick and ArmonAir RespiClick, will be available for adolescent and adult patients via prescription later this year.
US FDA approves 2 Teva Pharmaceutical asthma inhalers
Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection
Japan M&A By the Numbers: Q4 2023
Essential IR Insights Newsletter Fall - 2023
A Corporation Clearly Pinpoints Activist Investor Activity
The U.S. FDA approved two Teva Pharmaceutical Industries Ltd. asthma inhalers.
The inhalers, AirDuo RespiClick and ArmonAir RespiClick, will be available for adolescent and adult patients via prescription later this year.